Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's disease (Q28080770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's disease (English)

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Mariana Casalía

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

Verónica Cavaliere Candedo

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

Juan Cruz Casabona

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

Shirley D Wenker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

1 reference

28 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

volume

589

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

issue

22

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

3396-3406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26226418 AND SRC:MED&resulttype=core&format=json

Induced pluripotent stem cells: current progress and potential for regenerative medicine

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Technological overview of iPS induction from human adult somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Modeling Parkinson's disease using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Using stem cells and iPS cells to discover new treatments for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Reprogramming cellular identity for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Reprogrammed cells for disease modeling and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of embryonic stem cells: limitations of and alternatives to inner cell mass harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Non-viral methods for generating integration-free, induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Transcription factor-mediated reprogramming: epigenetics and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Meningeal cells induce dopaminergic neurons from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

A drug-inducible system for direct reprogramming of human somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Nuclear reprogramming and pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cell (iPSCs) and their application in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of pluripotent stem cells via protein transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

A review of the methods for human iPSC derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

A blueprint for engineering cell fate: current technologies to reprogram cell identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Multipotent stem cells from adult olfactory mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Modeling human brain development with cerebral organoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

HLA-haplotype banking and iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Nonviral methods for inducing pluripotency to cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

iPS cell technologies: significance and applications to CNS regeneration and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Advances in reprogramming somatic cells to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP and rotenone models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

iPSC crowdsourcing: a model for obtaining large panels of stem cell lines for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cells as a source of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

A simplified method to generate serotonergic neurons from mouse embryonic stem and induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Banking on iPSC--is it doable and is it worthwhile

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cell generation using a single lentiviral stem cell cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotency: history, mechanisms, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Fetal tissue transplantation: can it be morally insulated from abortion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Stage-specific role for shh in dopaminergic differentiation of human embryonic stem cells induced by stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Toward the development of a global induced pluripotent stem cell library

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Induced pluripotent stem cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Dopaminergic differentiation of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP toxicity and GDNF neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2015.07.023